Transplant News and Research

RSS

High dosage of ursodeoxycholic acid does not help PSC patients

A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.

29 Aug 2009

Two human biomarker assays that play a key role in the early detection of kidney damage provide assistance in drug development

Geneuity Clinical Research Services announces the recent validation and use in clinical trials of two human biomarker assays that play a key role in the early detection of kidney damage.

29 Aug 2009

Caucasians have a higher rate of HBV recurrence compared to Asian Americans and African Americans

According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV). Prior studies have shown there to be significant racial differences in access to and outcomes of liver transplantation. Recently, doctors from across the U.S. conducted a multicenter retrospective-prospective study of the waitlist status and outcomes of liver transplant patients with HBV infection.

28 Aug 2009

80 million American men and women suffer from male or female pattern hair loss according to a study

While lately most people are skeptical about their return on investment from stocks, it appears they have no qualms about making a solid investment in their locks.

27 Aug 2009

Urgent requirement for O negative blood group in Memorial Blood Centers

The need for blood never takes a vacation. Every two seconds, someone in our community needs blood. From premature infants to an organ transplant recipient who will typically require 40 units of blood to survive. And right now, the need is urgent. We are currently facing a shortage of Type 0 negative, the universal blood type that can be given to save the life of anyone, from premature infants and children having heart surgery to an organ transplant recipient who will typically require 40 units of blood to survive. Type B negative blood also is urgently needed.

27 Aug 2009

Studies suggest that venous ischemia causes greater injury than arterial ischemia

The research team led by Professor Guzman-de la Garza of the Autonomous University of Nuevo Leon, Mexico, used a rodent model of intestinal I/R to study the different inflammatory mediators that are associated with venous, arterial or total vascular occlusion.

27 Aug 2009

Research study indicates that liver regeneration could affect the metabolism of tacrolimus in LDLT

Several studies have shown that living donor liver transplant (LDLT) recipients required smaller doses of tacrolimus compared with deceased donor liver transplant (DDLT) patients, which indicated that liver regeneration could affect the metabolism of tacrolimus in LDLT.

27 Aug 2009

MedAssets to deliver transformational revenue cycle solutions for Saint Barnabas Health Care System

MedAssets, Inc. today announced that it has signed a long-term agreement to deliver its transformational revenue cycle solutions to Saint Barnabas Health Care System (SBHCS), the largest integrated health care delivery system in New Jersey. MedAssets will provide revenue cycle process reengineering services, powered by the continued deployment of web-based software and execution of ongoing primary accounts receivable billing and follow-up services.

26 Aug 2009

TBI and NWTS to serve surgeons and hospitals by supplying transplantable tissues

TBI/Tissue Banks International, one of the nation's largest eye and tissue banking networks, and Northwest Tissue Services (NWTS), a Puget Sound Blood Center program, have entered into a partnership that will allow both organizations to more efficiently serve surgeons and hospitals that rely on them for transplantable tissue.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Seattle Genetics completes enrollment of its pivotal clinical trial of brentuximab vedotin

Seattle Genetics, Inc. today announced that it has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30 utilizing the company’s proprietary ADC technology.

25 Aug 2009

Combined therapy for acute leukemia shows promising results

Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.

25 Aug 2009

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

Diplomat Specialty Pharmacy announced today that its Diplomat Health Services Division is partnering with CareSource in Ohio to slow the progression of Chronic Kidney Disease (CKD), improve clinical outcomes and reduce healthcare costs associated with the disease. As the number of Americans with CKD continues to rise, CareSource is focused on the early identification and treatment of their patients with the illness.

25 Aug 2009

INSERM researchers engineer a chimeric protein that improves stem cell engraftment

Researchers at INSERM (France) have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment. The results, which appear in the September 2009 issue of Experimental Biology and Medicine, show that TAT-Tpr-Met, a cell permeable form of the hepatocyte growth factor receptor can increase the number of hepatic stem cells integrated into the liver of the mouse.

24 Aug 2009

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

As thousands of people plan getaways for the fall and winter travel seasons, easy access to healthcare is a concern for many travelers with chronic health conditions who require life-sustaining treatments. Twenty-six million Americans suffer from chronic kidney disease, and more than 355,000 of them require dialysis every few days to stay alive.

24 Aug 2009

Research study reveals that mortality remains high in patients with pulmonary arterial hypertension

Mortality remains high among patients with pulmonary arterial hypertension awaiting lung transplant, despite changes to the allocation system that were designed to reduce mortality and increase the equitable distribution of donor organs, according to new research out of University of California San Francisco.

24 Aug 2009

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

A cellular molecule that not only can sense two common respiratory viruses but also can direct cells to mount a defense has been identified by microbiologists at The University of Texas Health Science Center at San Antonio.

24 Aug 2009

The California Chronic Care Coalition launches new website to share information on chronic conditions

The California Chronic Care Coalition (CCCC) continues to advance its work toward meaningful and responsible health care reform with the launching of its consumer website: www.chroniccareca.org. Designed to help build a healthier California, the website is aimed at the more than 16 million Californians with chronic conditions such as Asthma, Diabetes, Alzheimer’s Heart disease, Epilepsy and Multiple Sclerosis.

24 Aug 2009

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

HeartWare International, Inc. (Nasdaq: HTWR - ASX: HIN) today announced that HeartWare has surpassed 50 implants in the United States under its ADVANCE Clinical Trial, marking an important early enrollment milestone.

21 Aug 2009

Night home hemodialysis offers similar benefits as kidney transplants

For the first time, it has been shown that patients who receive night home hemodialysis live just as long as those who receive kidney transplants from deceased donors.

21 Aug 2009

Transplant News and Research

High dosage of ursodeoxycholic acid does not help PSC patients

Two human biomarker assays that play a key role in the early detection of kidney damage provide assistance in drug development

Caucasians have a higher rate of HBV recurrence compared to Asian Americans and African Americans

80 million American men and women suffer from male or female pattern hair loss according to a study

Urgent requirement for O negative blood group in Memorial Blood Centers

Studies suggest that venous ischemia causes greater injury than arterial ischemia

Research study indicates that liver regeneration could affect the metabolism of tacrolimus in LDLT

MedAssets to deliver transformational revenue cycle solutions for Saint Barnabas Health Care System

TBI and NWTS to serve surgeons and hospitals by supplying transplantable tissues

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Seattle Genetics completes enrollment of its pivotal clinical trial of brentuximab vedotin

Combined therapy for acute leukemia shows promising results

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

INSERM researchers engineer a chimeric protein that improves stem cell engraftment

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

Research study reveals that mortality remains high in patients with pulmonary arterial hypertension

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

The California Chronic Care Coalition launches new website to share information on chronic conditions

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

Night home hemodialysis offers similar benefits as kidney transplants

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News